Delta-Fly Pharma, Inc. (TYO:4598)
647.00
+44.00 (7.30%)
May 30, 2025, 3:30 PM JST
Delta-Fly Pharma Statistics
Total Valuation
TYO:4598 has a market cap or net worth of JPY 6.30 billion. The enterprise value is 5.96 billion.
Market Cap | 6.30B |
Enterprise Value | 5.96B |
Important Dates
The last earnings date was Thursday, May 15, 2025.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TYO:4598 has 9.73 million shares outstanding. The number of shares has increased by 22.38% in one year.
Current Share Class | 9.73M |
Shares Outstanding | 9.73M |
Shares Change (YoY) | +22.38% |
Shares Change (QoQ) | +7.58% |
Owned by Insiders (%) | 12.46% |
Owned by Institutions (%) | 6.82% |
Float | 7.94M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 22.81 |
P/TBV Ratio | 22.81 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.46 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.53
Current Ratio | 2.53 |
Quick Ratio | 2.49 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -228.40% and return on invested capital (ROIC) is -141.67%.
Return on Equity (ROE) | -228.40% |
Return on Assets (ROA) | -111.90% |
Return on Invested Capital (ROIC) | -141.67% |
Return on Capital Employed (ROCE) | -614.39% |
Revenue Per Employee | n/a |
Profits Per Employee | -132.38M |
Employee Count | 13 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | -0.93 |
52-Week Price Change | n/a |
50-Day Moving Average | 512.26 |
200-Day Moving Average | 558.61 |
Relative Strength Index (RSI) | 74.74 |
Average Volume (20 Days) | 380,855 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -1.71B |
Pretax Income | -1.72B |
Net Income | -1.72B |
EBITDA | -1.71B |
EBIT | -1.71B |
Earnings Per Share (EPS) | -195.56 |
Balance Sheet
The company has 338.00 million in cash and n/a in debt, giving a net cash position of 338.00 million or 34.74 per share.
Cash & Cash Equivalents | 338.00M |
Total Debt | n/a |
Net Cash | 338.00M |
Net Cash Per Share | 34.74 |
Equity (Book Value) | 276.00M |
Book Value Per Share | 28.42 |
Working Capital | 238.00M |
Cash Flow
Operating Cash Flow | -1.83B |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TYO:4598 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.38% |
Shareholder Yield | -22.38% |
Earnings Yield | -27.34% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |